Viewing Study NCT01730833

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2026-03-04 @ 5:59 AM
Study NCT ID: NCT01730833
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-03
First Post: 2012-11-16
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer
Sponsor: City of Hope Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-positive Breast Cancer View
None Recurrent Breast Cancer View
None Stage IIA Breast Cancer View
None Stage IIB Breast Cancer View
None Stage IIIA Breast Cancer View
None Stage IIIB Breast Cancer View
None Stage IIIC Breast Cancer View
None Stage IV Breast Cancer View
None Breast Adenocarcinoma View
None Inflammatory Breast Carcinoma View
Keywords: